is glp 1 for men and women Vitamatic GLP-1 Support Supplement & 60 Capsules More and more midlife and

Cheng, Z

Medications like orforglipron (an oral, non-peptide GLP-1 agonist), survodutide (a dual glucagon/GLP-1 agonist), and CagriSema (combining cagrilintide with semaglutide) are advancing through clinical trials

While some experts and researchers have concerns about the drugs long-term impact and safety, many argue the benefits outweigh the known risks.

Pharmacotherapy 37 , 927943 (2017)

The first effect is obvious

The SUSTAIN-6 Trial (Once-Weekly Semaglutide) The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) consisted of 3297 people living with T2DM, 83% with established cardiovascular disease, receiving once-weekly semaglutide (0.5 and 1.0 mg) or placebo